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Highlights: 
 This is the first study that highlights the sympathetic predominance during mania using 
non-linear HRV assessment tools such as Recurrence Plots and Symbolic Analyzes, 
proving clinical improvement after treatment. 
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Abstract 
Background – Bipolar Disorder (BD) has been associated with autonomic nervous system 
(ANS) dysregulation, with a consequent increase in mortality. Recent work highlights the 
non-linear analysis of ANS function. Our objective was to compare ANS modulation using 
recurrence plots (RP) and symbolic analysis (SA) in manic and euthymic phases of BD to 
controls. Methods – Eighteen male patients (33.1±12.0 years) were assessed during mania and 
at discharge in the euthymic phase compared and to a healthy group matched by age 
(33.9±10.8 years). Electrocardiographic series (1,000 RR intervals, at rest, in supine position) 
were captured using Polar Advantage RS800CX equipment and Heart Rate Variability (HRV) 
was analysed using RP and SA. Statistical analysis was performed using ANOVA with Tukey’s 
post-test. The threshold for statistical significance was set at P < 0.05 and Cohen’s d effect size 
was also quantified considering d > 0.8 as an important effect. The study was registered into 
the Clinical Trials Registration (ClinicalTrials.gov: NCT01272518). Results: Manic group 
presented significantly higher linearity before treatment (P<0.05) compared to controls 
considering RP variables. Cohen's d values had a large effect size ranging from 0.888 to 1.227. 
In the manic phase, SA showed predominance of the sympathetic component (OV%) with 
reduction of the parasympathetic component (2LV% and 2UV%) with reversion post treatment 
including higher Shannon Entropy (SE) indicating higher complexity. Limitations - short follow-
up (1 month) and small number of patients. Conclusions - Non-linear analyzes may be used as 
supplementary tools for understanding autonomic function in BD during mania and after drug 
treatment. 
 
Keywords: Recurrence Plots; Symbolic Analysis; Bipolar Disorder; Autonomic 
Nervous System; Heart Rate Variability; Nonlinear Domain.  




Autonomic Nervous System (ANS) dysregulation has been associated with bipolar disorder (BD) 
and others mental conditions1,2 and to the risk of cardiovascular diseases3-6. Data on mortality 
related to cardiovascular diseases in bipolar patients have been reported since the beginning 
of the 20th century7 – perhaps due to autonomic imbalance8, and seems to occur earlier 
compared to general population9,10. Contemporary clinical studies continue to demonstrate 
such association8,11,12 with high prevalence of risk factors for cardiovascular disease including 
diabetes mellitus, hypertension and obesity12-14.  
This autonomic dysregulation can be evaluated by heart rate variability (HRV)15, a measure 
that provides information relating to complex heartbeat dynamics that has important 
implications for psychophysiological and pathological states5. HRV can be used as an ANS 
integrity index for emotional states16, where individuals with lower HRV have impaired 
emotional regulation17, reflecting a feedback process between cortical, subcortical and 
cerebral trunk structures that regulate autonomic activity and human behavior18, linking HRV 
and brain networks17.  
Several authors have demonstrated autonomic dysfunction and central autonomic network 
disturbances in BD19,20, with reduced HRV a notable finding2,21-23. Linear analysis, both in time 
and in the frequency domain, have been commonly used2,21-23. However, nonlinear domain 
measures of HRV have also been studied24,25 and are based on the complex systems theory25. 
The analysis of nonlinear data may provide greater accuracy in clinical diagnosis25,26.  
The methods of recurrence analysis by means of recurrence plots (RP), a visual representation 
of a given time-series data, have been used successfully in different areas27-30. Recurrence 
quantification analysis (RQA) is currently considered an important method for non-linear data 
analysis of several complex systems31 and quantifies the number and duration of recurrences 
of a dynamical system presented by its space trajectory through the analysis of line inspection 
patterns30. This method has been shown to be useful in the diagnostic and prognostic 
evaluation in health and disease conditions and in the different age ranges26. Another method 
of non-linear HRV analysis is symbolic analysis (SA). This is a methodology that symbolizes the 
temporal course of one or more of the variables that describe the behavior of the dynamic 
system to study the complexity of this dynamic system as well as to evaluate the interactions 
between its parts32,33. It is emphasized that, a previous study in human being using cardiac 
pharmacological blockades established the cardiac autonomic representation of the symbols34. 
Thus, there has been interest in assessing nonlinear methods of HRV analysis to characterize 
autonomic cardiac function35 as nonlinear analyses are good predictors of cardiac 
dysfunction36 compared to time and frequency domain analyses, and also because they 
sufficiently characterize the complex dynamics of heartbeat generation since the mechanisms 
involved in cardiovascular regulation interact with each other in a nonlinear way25. 
         
 Some non-linear methods focus mainly on the aspect of uncertainty, also understood 
as complexity, considering that the greater the uncertainty of a system, the greater its 
complexity or entropy. Translating to the physiological aspect, if an individual has good HRV, 
there will be greater uncertainty (or irregularity, or complexity) between the RR intervals and 
therefore it will be an indication of good homeostasis, the reverse occurring with sick 
individuals because the intervals will be much more regular and therefore less uncertainty (less 
entropy) in the system25,32,33. It is recognized that time and frequency domain variables do not 
assess the complexity of the systems. In addition, not all nonlinear variables measure 
complexity (or entropy). This was the justification for this work to have used variables that 
relate to non-linearity and variables that are strictly associated with complexity or uncertainty 
(Shannon entropy; SE)25,32,33.  
 To our knowledge, this would be the first study to simultaneously use RP and SA to 
assess autonomic behavior in patients with BD before and after treatment, potentially allowing 
the detection of the effective individual contribution of each autonomic component. This study 
aimed to prospectively evaluate patients in the manic phase of BD considering changes in 
clinical status and its autonomic complex alterations, verifying the existence of changes with 
reversal to euthymia after treatment, as well as to compare BD patients with healthy 




Eighteen male patients (age: 33.1±12.0 yo) in the manic phase of BD and hospitalized 
were accompanied from the time of admission until discharge over a period of 
approximately 1 month. All participants underwent a diagnostic assessment by a 
psychiatrist member of this study group (GLLW), based on the Mini International 
Neuropsychiatric Interview (MINI) Brazilian version 5.0 - DSM IV
37
 on admission, as 
well as the Portuguese-validated version of the Bech-Rafaelsen Mania Scale (BR-
MaS)
38
 and in accordance with recommendations designed by Guidelines for Reporting 
Articles on Psychiatry and Heart Rate Variability (GRAPH) de Quintana et al.
39 
BD participants were excluded if they presented with any associated neurological 
condition or had already received prior electroconvulsive therapy; had a prior history of 
cardiovascular or metabolic disease or associated medications; had a prior history of 
drug use; displayed psychomotor agitation not allowing resting HRV recordings. 
Exclusion criteria were determined during an intensive clinical interview with one of the 
authors (GLLW). All patients underwent a 1-week wash-out period, and soon 
aripiprazole in combination with lithium was introduced for the treatment of the manic 
phase. Patients were on no additional medications. The first HRV measurement took 
place six days following the introduction of the drug combination, and the second 
measurement occurred on the day of discharge, when the same drugs were still in use. 
We considered the baseline measurement of HVR (first measurement) after the first 6 
         
days that is when the serum lithium, in general, reaches the pharmacokinetic state of 
equilibrium, although still without clinical response
40
.  
Mean dosages of aripiprazole and lithium were 15.0±5.8 mg and 900.0± 283.8 mg, 
respectively. The mean serum lithium concentration was 0.85±0.13 mmol/L. 
Eighteen healthy male individuals (age: 33.9±10.8 years old) comprised the control 
group. The study was approved by the local ethics committee (n° 459/2010), written 
inform consent was obtained, and the study was registered at Clinical.Trials.gov 
(identifier NCT01272518).  
 
2.1. HRV Analysis 
HRV recording is in accordance with standardization checklist of procedures by Catai et 
al.
41 
and by specific guidelines of Quintana et al.
39
. Data was collected between the 
hours of 11:00 am and 01:00 pm, while participants were spontaneously breathing in a 
resting dorsal decubitus position for 20 minutes. RR intervals were measured with the 
Polar RS 800 CX (Polar, Kempele, Finland) using a heart rate chest strap monitor 
placed over the distal third of the sternum from which data was transmitted to a wrist 
sensor. The signals were captured with this equipment in units of time fixed at 1ms and 
the samples of RR intervals were collected at a frequency of 1000 Hz. This 
methodology has been validated in relation to Holter system and has demonstrated to 
provide accurate and reliable data
42
.  All subjects in the control group followed the same 
methodology for HRV assessment
41
. We selected 1,000 RRi for HRV non-linear 
analysis, following the recommendations of Voss et al 2006
43
, which suggests that this 
approach should be used with short-term recordings approximately 20 min
43
.   
2.2. Linear analysis  





was performed by the Fast Fourier Transform and analysed in low (LF: 0.04-0.15 Hz) 
and high frequency (HF: 0.15-0.50 Hz). Data was presented in absolute units (LFabs 
and HFabs) and in normalized units (LFnu and HFnu). The normalization consisted of 
dividing the LF power by the total power minus the power below 0.04 Hz, multiplying 
the ratio by 100
15
. The LFnu represents sympathetic cardiac modulation. The HF 




2.3. Analysis of Recurrence Plots 
Recurrence plots were constructed with the following parameters: dimension=2, time delay=2, 
ratio=70, line=2 and Volcano scheme, using Visual Recurrence Analysis 5.01 software 
         
(http://visual-recurrence-analysis.software. informer.com; Eugene Kononov), which aids 
researchers in qualitative and qualitative analysis of Recurrence Plots. 
The recurrence quantification analysis (RQA) measures the recurrence point density, diagonal 
and vertical line structures of the RP, identifying and quantifying the transitions between 
periodic, laminar, and chaotic states26,28,30. The analyzed quantitative variables were mean RR 
(mean of RR Intervals), Standard Deviation of the average of normal RR intervals (SDNN), 
Recurrence Rate (REC% - the percentage of recurrence points in an RP, corresponding to the 
correlation sum), Determinism (DET% - the percentage of recurrence points forming diagonal 
lines), Laminarity (LAM - the percentage of recurrence points forming vertical lines), Trapping 
Time (TT - the average length of the vertical lines), Shannon Entropy (SE - measures the 
complexity of the system) and Longest Diagonal Line (Lmax)26,28,30.  
 
2.4. Symbolic Analysis  
The HRV symbolic analysis, described by Porta et al.32,43,44, is based on the RRi transformation 
into a sequence of symbols, from the classification of the RRi in six levels (0 to 5). The 
sequence of symbols gives rise to the patterns (sequence of 3 symbols). All possible patterns 
were grouped, without losses, in 4 families, according to the number and type of variations 
between subsequent symbols: 1) 0V: pattern without variation (3 equal symbols), 2) 1V: with 
one variation (2 identical symbols and one different), 3) 2LV: pattern with 2 equal variations 
(the 3 symbols form an ascending or descending ramp) and 4) 2UV: pattern with 2 different 
variations (the 3 symbols form a peak or a valley). The occurrence rates of these families were 
calculated (0V%, 1V%, 2LV% and 2UV%). 
Guzetti et al.34 have shown that the 0V% index represents sympathetic cardiac autonomic 
modulation, the indexes 1V% and 2LV% represent the sympathetic and parasympathetic 
cardiac modulation, and 2UV% represents the parasympathetic cardiac modulation32,41. In this 
same way, the HRV complexity analysis was performed using the Shannon entropy (SE). This 
analysis measures the complexity of distribution of the patterns (sequences of three symbols) 
obtained in the time series RRi selected32,44. The index is high if the distribution is flat (all 
patterns are equally distributed and the series carries the maximum information), while the 
index is low if some patterns are more likely, others missing or absent32,44. 
 
2.5. Data analysis  
For analysis of intervals between heart beats it is necessary to remove artifacts, impulses not 
initiated by the sinoatrial node and interferences.  Noise effects were appropriately filtered 
according to T-RR Filter 1.1 beta45. The used filtering algorithm removes the RR intervals 
shorter than 350 ms, that are equivalent to the absolute or relative refractory periods and also 
         
because such intervals may represent an increase in the heart rate which is incompatible with 
the normal sinus rhythm. This step also removes RR intervals longer than 1,200 ms. Comparing 
with the conventional filtering methods, which requires an expert to manually remove ectopic 
beats in the processing of HRV time series, this software allows that HRV analysis can be 
efficiently and quickly performed using an automatic adaptive filtering method45.  
Statistical analysis was performed with commercially available software (StatsDirect version 
1,9,15 – 2002). For comparative analysis between the three groups (euthymia, mania and 
controls) One-Way Analysis of Variance was used, applying the F test (variance ratio). In the 
case of P values less than or equal to 0.05, the post test of multiple comparisons of Tukey was 
used. The values for Bech-Rafaelsen Mania Scale (BR-MaS)38 applied to assess the severity and 
evolution of the manic episode in the studied patients were presented as median and range 
because they are generated as an ordinal qualitative scale1 (range: 0 – 7) and were compared 
between mania and euthymic groups using the Wilcoxon's signed ranks test. Ordinal 
qualitative variable does not allow averaging since they are not true numbers. Descriptives 
results were expressed as mean ± SD or median (range) as adequate. The association between 
the changes in the HRV indices in RP and changes in the symbolic analysis was assessed by 
Spearman’s correlation coefficient. A P-value < 0.05 was considered as significant, and Cohen’s 
d effect size measures were determined for all pair-wise comparisons Cohen’s d effect size46 
was also quantified considering d > 0.8 as an important effect. 
 
3. 3 RESULTS 
 
The Bech-Rafaelsen Mania Scale (BR-MaS) applied to assess the severity and evolution 
of the manic episode in the studied patients showed at admission a median of 19.8 
(range: 12 – 39) and at discharge a median of 1.10 (range: 0 – 7) (P<0.0001; Wilcoxon's 
signed ranks test). 
Recurrence quantification analysis (RQA) results show quantitative differences and also 
expressive differences in visual patterns of recurrence plots between controls and patients. 
The visualization of each group highlights the more geometric and repetitive aspect of the 
manic state in contrast to a more diffuse and uniform distribution in the control group, while 
the euthymic group presents as intermediate between the control group and the patient group 
at baseline. These observations provide evidence of the occurrence of physiological changes in 
BD, which justifies the use of the analysis of recurrence in the diagnostic and therapeutic 
arsenal for this disorder (Figure 1; Table 1) 
 Calculations of Cohen's d values46 for quantification of effect size on the six studied 
variables in the recurrence plot (REC%, DET%, LAM, TT, Entropy and Max Line) indicated large 
effects, ranging from 0.888 to 1.227 (Table 2). 
         
It was also observed that the recurrence measures obtained from the recurrence 
quantification analysis (RQA) of the post-treatment group clearly approached the values of the 
control group. An objective assessment of this fact is that of the nine variables studied, seven 
were significantly different in the comparison between mania and euthymia, while for the 
same nine variables, only one was significantly different in the comparison between euthymia 
and control.  
 Table 1 also presented the indices of SA and SE of the studied groups. The Mania phase 
was statistically different from Control and Euthymia. The mania phase had higher value of 
0V%, representative of sympathetic modulation, lower values of 1V% and 2LV% (double 
modulation) and lower value of 2UV%, representative of the parasympathetic modulation. The 
SE was different in the mania phase when compared to Euthymia, where the mania presented 
lower values. 
 Table 3 presented the results from linear analysis. The RRi mean was different when 
comparing the studied 3 groups. Controls showed the highest values and mania the lowest. For 
STD, control was greater when compared to mania and euthymia. The spectral analysis shows: 
LFabs was higher in control subjects when compared to mania and euthymia patients. The 
LFnu, representative of cardiac sympathetic modulation, was higher in mania compared to 
euthymia. The HFabs was higher in control compared to mania and in the normalized units 
(HFnu), mania showed lower values compared to euthymia. These findings agree with the data 
of the symbolic analysis. 
Table 4 shows the correlations obtained between the variables of the symbolic dynamics and 
the variables of the RP. Positive correlation between RP indexes and OV% was highlighted, 
suggesting an association between linearity and sympathetic modulation. On the other hand, 
the negative correlation between RP indexes and 2UV% is clear. 
 
4. 4. DISCUSSION 
 
The main findings of this study  are follows: 1) Patients with BD have alterations in the 
nonlinear HRV dynamics consistent with high sympathetic heart modulation, reduced vagal 
modulation and lower complexity of HRV, compared to healthy individuals; 2) After treatment, 
it was possible to observe reduction of sympathetic modulation and increase of vagal 
(parasympathetic) modulation as well as increase of complexity, with no difference from 
controls, demonstrating improvement of the nonlinear HRV dynamics and treatment of the 
disease; 3) RP indexes correlated with symbolic indexes, making it possible to improve the 
interpretation of BD cardiac autonomic modulation; 4) RP and SA: were able to clearly show 
the clinical transition from mania to euthymia in patients with BD. 
         
In recent years, systematic reviews and meta-analysis aimed at addressing the HRV responses 
in BD have been published47-49, where there were no reports of studies that used Analysis of 
Recurrence Plots and only one study, described by Torre-Luque et al.48, used symbolic 
dynamics for HRV analysis, but it was used to assess motor activity in mania, bipolar 
depression and healthy controls50. Therefore, our study adds in the literature, results from 
bipolar disorder in mania and euthymia using non-linear analysis little explored so far. 
The HRV in BD has been evaluated in resting supine23,24,26 and other conditions such as sleep51 
and at rest while sitting52. Although the difference in assessment condition, the results are 
consistent with studies at rest, where there is a decrease in HRV assessed by several methods. 
The study by Migliorini et al.51 evaluated HRV (time and frequency domain, sample entropy, 
Lampel-ziv complexity, DFA, 1/f slope) and concluded that HRV is reduced in depression and 
bipolar disorder. The study of Henry et al.52 was performed in sitting position in manic BD 
patients and schizophrenia. They performed several analyses (HR, SDNN, RMSSD, pNN50, 
spectral analysis and dynamic entropy and concluded that individuals with manic BD 
demonstrated a decrease in HRV as assessed by several measures. 
Considering the ANS in the control of cardiovascular activity, and the possibility that its 
dysregulation precedes the beginning of major mood disorders22, some authors correlate 
autonomic dysfunction with psychiatric symptoms23,53,54, showing that the loss of vagal 
modulation is not restricted to the cardiac system. The present work showed the existence of 
autonomic dysfunction of the different branches of the ANS in patients with BD, a psychiatric 
disease with disorders of the central autonomic network20, where reduction of HRV was also 
reported22,23, with predominance of sympathetic modulation during mania and autonomic 
remodeling after treatment, with predominance of vagal modulation.  
Most of the studies suggest that the predictive model of mental illness based only on standard 
diagnostic assessments is not adequate for the accuracy and replicability of the diagnosis and 
that other models of analysis considering the dynamic characteristics of these disorders would 
present greater predictability of which patients would change from one clinical state to 
another54. 
Valenza et al.55 reported that heartbeat nonlinear dynamics are able to predict mood changes 
in BP. In our present work, the RP and Symbolic Analysis, nonlinear model of complex system 
analysis, were able to clearly show the clinical transition from mania to euthymia in patients 
with BD (Table 1 and 3), showing the cardiac autonomic modulation is significantly altered in 
untreated patients, allowing a non-invasive way of observing ANS changes after treatment.  
One of the relevant aspects of SA is that this method allows to specifically differentiate the 
sympathetic component (0V%) from the parasympathetic component (2V%)32,34 and thus allow 
the correlation with RP variables regarding this differentiation. In our study, for SA, it was 
observed that in the mania there was a predominance of the sympathetic component (OV%) 
and a reduction of the parasympathetic component (2LV% and 2UV%) (Table 3). We can then 
infer that 0V% increase is associated with less variability or greater recurrence of the elements 
of the system. 
         
To our knowledge, this is the first time that were studied RP and SA simultaneously in BD and 
that was possible to make correlations and pathophysiological associations with symbolic 
analysis, in terms of sympathetic and parasympathetic functioning.  
In our present study, in relation to the state of mania, when using RP, we could observe a 
higher REC% and higher SE, indicating a higher linearity and lower homeostasis. In this analysis, 
the SE is related to determinism and measures the complexity of the diagonals, showing higher 
values during mania, clearly indicating less complexity of the system and, therefore, greater 
linearity. This can be confirmed after treatment, where there was improvement of the cardiac 
ANS and the patients in the euthymia presented no difference in relation to the controls. 
These observations provide evidence of the occurrence of physiological changes in BD, which 
justifies the use of the analysis of recurrence in the diagnostic and therapeutic arsenal for this 
disorder. 
There is a clear difference between the interpretation of SE values using RP or SA. This 
difference is due to the fact that, in the symbolic analysis, the SE is a measure of the 
complexity of the possible "words" of the system and, the greater the number of words, the 
greater the variability and therefore the greater complexity, indicating better physiological 
conditions but, in the recurrence graph, SE is a measure of the complexity of the "diagonals" 
present in the system and since diagonals represent determinism, the higher the SE value, the 
greater the system determinism, indicating greater linearity and lower homeostasis of the 
organism25. 
Patients diagnosed with serious mental disorders may die earlier than the general population, 
reducing life expectancy56,57. BD has one of the highest suicide risks57,58, but also cardiovascular 
disease is one of the main cause of mortality8,12. The early and definitive diagnosis of mood 
disorders is important and, currently, the focus of the main scientific research in this area. 
Thus, the novelty of this study was correlating the RQA and SA variables with the sympathetic 
and parasympathetic functioning in BD. This noninvasive, simple, and a cost-effective analysis 
allows to monitor cardiovascular parameters before and after treatment compared to healthy 
individuals and to observe autonomic alteration in advance and thus enable to treat the 
patient before the symptoms of the disease reappear.  
Voss et al.43 discussed about the Emotional Motor System (EMS) as a separate motor system 
that acts independently from the primary somatic motor system, with influences somatic 
system under limbic control. Some EMS (lateral part) structures are related to specific 
emotional reactions whereas the neurotransmitters systems (norepinephrine, serotonine, 
acetylcholine and dopamine) have an important role in the EMS medial part. Considering the 
cardiovascular functioning, cortical areas (mostly located in the frontal cortex) seem to be 
involved in both perception and the motor control and the overlap of the neurotransmitters 
and specific brain areas involved in the autonomic function and in the pathophysiology of 
some brain disorders would justify an autonomic dysfunction in BD.  
Studies on HRV has reported a variety of behaviors including positive mood states, 
emotional regulation, cognitive function, inflammatory processes and brain plasticity. 
Research considering HRV changes and the neurophysiology BD are rare, especially in 
the manic phase. Vagal dysfunction relates to poor homeostatic behavior and to 
         
increased morbidity and mortality
3-5
. Accordingly, to Martinez-Aran et al.
59
, patients 
with BD have deficits in executive control, learning and verbal memory, working 
memory and sustained attention, especially during manic phase, where neurotoxic 
pathophysiological changes (reduced brain-derived neurotrophic factor (BNDF) and 
increased inflammatory cytokines) are observed. Kemp et al.
4,5,60
 reported that HRV 
changes caused by the vagus nerve leading to normalized function indirectly stimulate 
neurogenesis through the expression of BNDF, with consequent cognitive improvement. 
Kemp et al.
4
 highlighted that another important mechanism to be considered, that is the 
association between vagal activity and social cognition, where low HRV may indicate 
difficulty in maintaining social relationships and emotional processing, especially 
during a manic phase
61
.  
The literature has given special emphasis to the use of non-linear methods in the assessment 
of autonomic behavior in mood disorders. Voss et al.43 revised the principal methods of time-
domain, frequency- domain, and nonlinear analyses of HRV, blood pressure variability, as well 
as methods for coupling and interaction analyses. In the study, the authors highlight especially 
the non-linear domain for the use of Detrended Fluctuation Analysis (DFA), Approximate 
Entropy (ApEn) and Symbolic Analysis (SA). The SA, as previously mentioned, allows a 
simplified description of the dynamics of a system with a limited amount of symbols. Voss et 
al.43 concluded their study stating that prospective studies of cardiovascular changes in mania 
and depression are needed to evaluate a psychopathological state in connection with 
cardiovascular changes and that these studies should consider the application of nonlinear 
methods, and a multivariate approach in addition to the traditional analysis of HRV.  
Todder et al.62 studied 32 euthymic bipolar patients and 24 controls both during complete rest. 
Nonlinear analysis (Poincare plot, largest Lyapunov exponent, minimal embedding dimension 
and symbolic dynamic) was used. They concluded that the nonlinear analysis of HRV didn’t 
support the notation that there is a disturbance in the autonomic nervous system of BD 
patients in the euthymic state.  Based on the results of our study, this conclusion is not 
completely right. We have demonstrated that actually there was no significant difference 
between euthymia and controls but the differences were quite evident between mania and 
euthymia showing that there is an evident disturbance in the autonomic nervous system of 
bipolar patients in the mania state, which can be reversed with the use of specific drugs. 
Valenza et al.55 also studied mood changes in BD and exclusively through heart beat nonlinear 
dynamics. They studied 14 bipolar spectrum patients (age: 33.43 ± 9.76, age range: 23–54; six 
females). Each patient was monitored twice a week, for 14 weeks, being able to perform 
normal unstructured activities.  Relatively to the nonlinear variables they studied more 
specifically, sample entropy (SampEn), Approximate entropy (ApEn), features from the 
recurrence plot by means of the recurrence quantification analysis (RQA), and the detrended 
fluctuation analysis (DFA). They were able to obtain personalized prediction accuracies in 
forecasting a mood state of 69% on average, reaching values as high as 83.3%. They concluded 
that this approach opens to the possibility of predicting mood states in bipolar patients 
through heartbeat nonlinear dynamics exclusively.  
         
Our results are in accordance with the available literature and so we concluded that these non-
linear analyses RP and SA provide important and complementary tools for the study of the 
evolution and prognosis of diseases with autonomic involvement as demonstrated in this study 
with BD, where drug treatment reestablished the autonomic functioning raising HRV values of 
manic patients to levels closer to that observed in control individuals in the euthymic phase.  
 
4.1. Limitations 
Although we were able to show patients' autonomic and clinical improvement after treatment, 
this study has some few limitations as the short follow-up (1 month) and small number of 
patients. Also, a convenience sample was used, characterized by all cases that sought the 
hospital for treatment and that met the inclusion criteria. The finding of significant statistical 
differences between the groups, in itself, validates the sample size used. Despite this, the 
sampling power was calculated a posteriori, based on the results of the symbolic analysis, 
indicating a power always greater than 95%. 
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Figure legends 
 
Figure 1. A representative case of Recurrence Plot visual patterns of each group: A) Pre-
treatment - manic state; B) Post-Treatment – euthymic state; and C) Controls - without 
BD.  
         
 
Figure 2. Correlation between HRV indices in RP and SA methods for all studied groups. A, 0V% 
or 2UV% pattern of symbolic analysis with DET%; B, 0V% or 2UV% pattern with Shannon 
Entropy; C, 0V% or 2UV% pattern of symbolic analysis with LAM; D, 0V% or 2UV% pattern of 
symbolic analysis with maxLine; E, 0V% or 2UV% pattern of symbolic analysis with REC%; F, 
0V% or 2UV% pattern of symbolic analysis with TT.  
         
 
Table 1. Age, symbolic and complexity analysis, and recurrence variables indices of HRV. 
Data are expressed as mean ± standard deviation; One Way ANOVA with Tukey Post-test. 
 
Variables Controls Mania Euthymia Group difference (p-value) 
 (a) (b) (c) a x b b x c a x c 
Age 33.9±10.8 33.1±12.0 33.1±12.0 0.9711 0.9711 >0.9999 
Symbolic Analysis       
0V% 28.37±12.9 46.68±14.09 29.97±11.74 0.0003* 0.0009* 0.9273 
1V% 47.67±5.07 40.51±8.28 47.38±4.99 0.0036* 0.0054* 0.9898 
2LV% 7.60±4.71 3.67±4.16 7.54±4.69 0.0322* 0.0356* 0.0584 
2UV% 16.39±6.43 9.18±3.32 15.02±5.69 0.0005* 0.005* 0.7235 
Complexity analysis 
Shannon Entropy 3.32±0.37 3.13±0.39 3.50±0.35 0.2758 0.0124* 0.3399 
Recurrence analysis       
REC% 37.1±4.1 39.4±3.7 36.6±2.7 0.1324 0.0488* 0.8885 
DET% 76.5±11.1 90.5±6.7 81.9±8.1 <0.0001* 0.0129* 0.1678 
LAM 87.2±6.7 95.0±3.0 90.7±4.1 <0.0001* 0.0266* 0.0928 
TT 5.0±1.9 10.2±5.0 6.1±2.5 0.0001* 0.0023* 0.6045 
ShanEntr 3.2±0.5 4.0±0.7 3.4±0.4 0.0003* 0.0067* 0.5637 
Lmax 86.9±63.1 383.7±304.6 113.00±66.7 <0.0001* 0.0002* 0.9048 
         
Table 2. Effect size evaluation (d Cohen) and correlation values (r) after 









Data are expressed as mean ± standard deviation and absolute 
measures of Cohen’s d effect size and its correlation values (r). 
Variables Mania Euthymia          d R 
REC% 39.4±3.7 36.6±2.7 0.8888 0.4061 
DET% 90.5±6.7 81.9±8.1 1.1595 0.5016 
LAM 95.0±3.0 90.7±4.1 1.2041 0.5158 
TT 10.2±5.0 6.1±2.5 1.0126 0.4517 
ShanEntr 4.0±0.7 3.4±0.4 1.0341 0.4593   
Lmax 383.7±304.6 113.00±66.7 1.2276 0.5231 
         















Data are expressed as mean ± standard deviation; One Way ANOVA with Tukey Post-test.  
Variables Controls Mania Euthymia P- value 
 (a)          (b)             (c) a x b  b x c a x c  
Time domain Analysis 
Mean RR 919.6±103.4 712.8±87.7 796.6±102.5 <0.0001* 0.0353* 0.0012* 
STD (ms) 43.3(26.5-53.7) 21.8(9.7-28.6) 20.4(12.5-35.2) <0.05* - <0.05* 
SDNN 47.1±15.5 35.5±18.5 38.7±22.2 0.1681 0.8701 0.3836 
Frequency domain analysis 
LF abs 746.8(332.5-1064.8) 347.7(53.6-529.7) 238.4(63.7-614.4) <0.05* - <0.05* 
LF nu 73.7±16.4 81.3±9.6 67.3±14.4 0.237 0.011* 0.354 
HF abs 153.0(111.9-313.1) 71.4(10.8-94.8) 110.5(19.1-380.8) <0.05* - - 
HF nu 26.2±16.4 18.6±9.6 32.5±14.4 0.232 0.011* 0.363 
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Table 4. Correlation between heart rate variability RP and SA indices. 
 REC% DET% LAM TT Entropy maxLine 
All volunteers 
%0V 0.753* 0.819* 0.755* 0.818* 0.854* 0.685* 
%1V -0.747* -0.669* -0.576* -0.839* -0.831* -0.658* 
%2LV -0.708* -0.585* -0.461* -0.646* -0.732* -0.553* 
%2UV -0.463* -0.817* -0.862* -0.557* -0.596* -0.505* 
Control Group 
%0V 0.515# 0.729# 0.632# 0.594# 0.687# 0.609# 
%1V -0.628# -0.585# -0.397 -0.607# -0.607# -0.543# 
%2LV -0.411 -0.385 -0.196 -0.432 -0.529# -0.464 
%2UV -0.243 -0.722# -0.813* -0.401 -0.514# -0.456 
Mania Group 
%0V 0.804 0.778 0.768# 0.825 0.856 0.689# 
%1V -0.812 -0.746# -0.705# -0.848 -0.861 -0.676# 
%2LV -0.774# -0.638# -0.627# -0.685# -0.775# -0.580# 
%2UV -0.413 -0.643# -0.716# -0.496# -0.404 -0.479# 
Euthymia Group 
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%0V 0.871* 0.801* 0.734* 0.869* 0.859* 0.837* 
%1V -0.613# -0.461 -0.416 -0.794* -0.758# -0.614# 
%2LV -0.886* -0.529# -0.383 -0.690# -0.774# -0.693# 
%2UV -0.551# -0.848* -0.869* -0.543# -0.489# -0.635# 
         
